|
Cytoplasmatic Therapy |
|||||
|
The original concept of live cell therapy was pioneered in Europe by the brilliant Swiss scientist Professor Paul Neihans in 1931, and further developed by his first pupil, the German Dr. Siegfried Block. However, although live cell therapy was enormously successful, it did carry with it a number of problems and disadvantages, and in recent years Professor Karl Theurer of Germany has completely revolutionized the entire concept.
The Theurer method takes fresh tissue from healthy animal stock, frees it from all extraneous matter and then pulverizes it at a temperature of minus 195 degrees. After being treated in an acid vapor vacuum without heat, the resultant dry powder is now composed of organ material of such tiny proportions that the body’s immune system is, in effect, deceived. The materials can be injected, or taken in tablet or capsule form. There is no tendency towards rejection or allergic response, and the increased solubility means less discomfort when injected into the patient. This form of biomolecular or cytoplasmatic therapy has been approved by the German FDA for more than fifty years, and is accepted as a legitimate medical treatment in over 60 countries. Today in Germany alone it is used as the principal method of treatment by more than 5,000 practicing physicians, and many other doctors prescribe individual courses of therapy for their patients.
|
Recommended Web Sites
|